最近在特定地点的脂质纳米颗粒的进展,用于mRNA输送
1Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States.
ACS nanoscience Au
|June 26, 2023
概括
使者RNA (mRNA) 疗法正在迅速发展. 特定位点的脂质纳米颗粒 (LNP) 增强mRNA输送,提高治疗疗效和减少副作用.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
背景情况:
- 由于疫苗的成功,信使RNA (mRNA) 疗法开发加速了.
- 由于mRNA的不稳定性,在体内应用中需要有效的输送载体.
- 脂质纳米颗粒 (LNP) 保护mRNA,并促进细胞内输送.
研究的目的:
- 审查现场特定mRNA输送策略的最新进展.
- 突出提高mRNA治疗功效的方法.
- 讨论减少mRNA疗法的非目标不良影响.
主要方法:
- 在局部注射后总结器官或组织特定的LNP策略.
- 详细说明静脉注射后特定器官或特定细胞的LNP策略.
- 审查各种特定地点的脂质纳米粒子输送系统.
主要成果:
- 特定部位的LNP能够在特定的器官,组织或细胞中有针对性的积累.
- 有针对性的治疗可以提高mRNA疗法的效率.
- 通过特定地点的交付,观察到减少了非目标效应.
结论:
- 特定位点的脂质纳米颗粒代表了先进的mRNA疗法的一个有前途的战略.
- 有针对性的治疗提高了治疗结果,并最大限度地减少了不良影响.
- 这些输送系统显著改善了mRNA治疗的未来前景.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


